Nxera Pharma Co., Ltd. (OTCMKTS:SOLTF) Short Interest Update

Nxera Pharma Co., Ltd. (OTCMKTS:SOLTF) was the recipient of a significant decrease in short interest in the month of September. As of September 15th, there was short interest totalling 2,006,700 shares, a decrease of 16.6% from the August 31st total of 2,405,300 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is currently 20,067.0 days.

Nxera Pharma Stock Performance

Nxera Pharma stock opened at $9.15 on Friday. Nxera Pharma has a fifty-two week low of $8.22 and a fifty-two week high of $13.43. The firm’s fifty day moving average price is $9.58 and its 200-day moving average price is $9.79.

Nxera Pharma Company Profile

Nxera Pharma Co, Ltd. develops and sells biopharmaceutical products in Japan, Switzerland, the United States, Bermuda, and the United Kingdom. Its product portfolio products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair and Breezhaler for the treatment of asthma; ORAVI, a novel formulation for the treatment of oropharyngeal candidiasis; and PIVLAZ for the treatment of cerebral vasospasm indications.